Back
Arcutis Biotherapeutics Quote, Financials, Valuation and Earnings
Sponsored
ARQT
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.14
Seasonality Move:
-24.31%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcutis Biotherapeutics Price Quote
$10.14
-0.25 (-2.41%)
(Updated: September 19, 2024 at 6:55 PM ET)
Arcutis Biotherapeutics Key Stats
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Day range:
$9.90 - $10.71
52-week range:
$1.76 - $13.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.65
P/B ratio:
6.51%
Volume:
2.3M
Avg. volume:
2.2M
1-year change:
61.59%
Market cap:
$1.2B
Revenue:
$59.6M
EPS:
$-2.19
How Much Does Arcutis Biotherapeutics Make?
-
How Much Are Arcutis Biotherapeutics's Sales Annually?
ARQT Revenues are $59.6M -
How Much Profit Does Arcutis Biotherapeutics's Make A Year?
ARQT net income is -$262.1M
Is Arcutis Biotherapeutics Growing As A Company?
-
What Is Arcutis Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.95% -
What Is Arcutis Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcutis Biotherapeutics Stock Price Performance
-
Did Arcutis Biotherapeutics Stock Go Up Last Month?
Arcutis Biotherapeutics share price went up by 22.38% last month -
Did ARQT's Share Price Rise Over The Last Year?
ARQT share price rose by 61.59% over the past 1 year
What Is Arcutis Biotherapeutics 52-Week High & Low?
-
What Is Arcutis Biotherapeutics’s 52-Week High Share Price?
Arcutis Biotherapeutics has traded as high as $13.17 over the past 52 weeks -
What Is Arcutis Biotherapeutics’s 52-Week Low Share Price?
Arcutis Biotherapeutics has traded as low as $1.76 over the past 52 weeks
Arcutis Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcutis Biotherapeutics?
-
How Much Debt Does Arcutis Biotherapeutics Have?
Total long term debt quarterly is $203.8M -
How Much Cash Does Arcutis Biotherapeutics Have?
Cash and short term investments quarterly total is $362.4M -
What Is Arcutis Biotherapeutics’s Book Value Per Share?
Book value per share is 1.60
Is Arcutis Biotherapeutics Cash Flow Positive?
-
What Is ARQT Cash Flow From Operations?
Cash flow from operations (TTM) is -$177M -
What Is Arcutis Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $263.4M -
What Is Arcutis Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$107.5M
Arcutis Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ARQT return on invested capital is -60.74% -
What Is Arcutis Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -52.91% -
What Is ARQT Return On Equity?
ROE is a measure of profitability and is -158.44%
Arcutis Biotherapeutics Earnings Date & Stock Price
-
What Is Arcutis Biotherapeutics's Stock Price Today?
A single share of ARQT can be purchased today for 10.39 -
What Is Arcutis Biotherapeutics’s Stock Symbol?
Arcutis Biotherapeutics trades on the nasdaq under the ticker symbol: ARQT -
When Is Arcutis Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Arcutis Biotherapeutics is scheduled on November 1, 2024 -
When Is ARQT's next ex-dividend date?
Arcutis Biotherapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Arcutis Biotherapeutics Stock?
You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcutis Biotherapeutics Competitors
-
Who Are Arcutis Biotherapeutics's Competitors?
Below is a list of companies who compete with Arcutis Biotherapeutics or are related in some way:
Arcutis Biotherapeutics Dividend Yield
-
What Is ARQT Dividend Yield?
Arcutis Biotherapeutics’s dividend yield currently is 0% -
What Is Arcutis Biotherapeutics’s Payout Ratio?
Arcutis Biotherapeutics’s payout ratio is 0% -
When Did Arcutis Biotherapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Arcutis Biotherapeutics’s Dividend Per Share?
Arcutis Biotherapeutics pays a dividend of $0.00 per share
Arcutis Biotherapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 20.76% |
Revenue: | 494.57% | 6.11% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 18.57 |
Upside from Last Price: | 78.74% |